BRD 4354 is primarily utilized in the field of medical research, particularly in the study of neurodegenerative diseases. It has shown potential in modulating specific biological pathways associated with conditions like Alzheimer's disease, making it a valuable compound for developing therapeutic strategies. Researchers are exploring its efficacy in targeting protein misfolding and aggregation, which are key factors in the progression of such disorders. Additionally, BRD 4354 is being investigated for its role in enhancing cognitive functions and reducing neuroinflammation in preclinical models. Its application extends to drug discovery programs aimed at identifying novel treatments for neurological and psychiatric conditions.